What is Stephens's price target for CDNA?

Stephens's latest stated price target for CareDx Inc. (CDNA) is $10, from its action on Nov 9, 2023.

What is Stephens's rating on CDNA?

Stephens rates CDNA Overweight, a bullish rating, as of Nov 9, 2023.

When did Stephens last change its view on CDNA?

On Nov 9, 2023, Stephens upgrades to Overweight from Equal-Weight, price target $10.

Stephens CDNA price target and rating history

Stephens rates CareDx Inc. (CDNA) Overweight with a $10 price target, as of its latest action on Nov 9, 2023. It has published 3 rating actions on CDNA since April 2022, including 1 upgrade and 1 downgrade.

Current rating: Overweight
Price target: $10
Median target, all firms: Too few
Actions on CDNA: 3

Stephens price target on CDNA

Stephens price target on CDNA, each point a stated target, April 2022 to November 2023.

Every Stephens rating on CDNA

Nov 9, 2023
UpgradeStephens upgrades to Overweight from Equal-Weight, price target $10
Mar 7, 2023
DowngradeStephens downgrades to Equal-Weight from Overweight, price target $19 to $9
Apr 25, 2022
InitiateStephens starts coverage at Overweight, price target $50

How other firms rate CDNA

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Canaccord Genuity	Buy	$65	Sep 2, 2026
Craig-Hallum	Buy	$64	Aug 3, 2026

Questions about Stephens and CDNA

What is Stephens's price target for CDNA?: Stephens's latest stated price target for CareDx Inc. (CDNA) is $10, from its action on Nov 9, 2023.
What is Stephens's rating on CDNA?: Stephens rates CDNA Overweight, a bullish rating, as of Nov 9, 2023.
When did Stephens last change its view on CDNA?: On Nov 9, 2023, Stephens upgrades to Overweight from Equal-Weight, price target $10.

More CDNA rating histories

All Stephens ratings CDNA news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.